[1]
C. Demir and E. S. Istifli, “Docking-based virtual screening, ADMET, and network pharmacology prediction of anthocyanidins against human alpha-amylase and alpha-glucosidase enzymes as potential antidiabetic agents”, Int. J. Plant Based Pharm., vol. 2, no. 2, pp. 271–283, Sep. 2022.